In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.
Haley Sutton
Advertisement
Haley Sutton is with Tanvex Biopharma USA, Inc. in San Diego, California.
Articles by Haley Sutton
Advertisement
Latest Updated Articles
Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC MethodPublished: June 28th 2024 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Green Stabilizers in Nitrocellulose Propellants: VOC Fingerprinting of Accelerated Aging by HS-SPME–GC×GC–TOF-MS
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
Reactivating Your GPC/SEC Instrument After Shutdown
4
The Scientist’s Value in the Age of Automation
5
